Lotus Award
The Lotus Award from Pershing Square Philanthropies funds innovative, cross-disciplinary research to drive breakthroughs in ovarian cancer detection, prevention, and treatment.
Funder: Pershing Square Philanthropies
Due Dates (Anticipated): February 2027: Letter of Intent deadline (projected)
Funding Amounts: $750,000 total ($250,000/year for 3 years, including up to 10% indirect costs)
Summary: Supports innovative, collaborative research to advance ovarian cancer breakthroughs, with emphasis on high-risk, high-reward ideas and cross-disciplinary collaboration.
Key Information: Only one application per PI/collaborator; if lacking ovarian cancer experience, a collaborator with such expertise is required.
Description
The Lotus Award, offered by Pershing Square Philanthropies, aims to catalyze transformative research in ovarian cancer—one of the most understudied and underfunded cancers. The program seeks to support radically innovative projects that could significantly impact early detection, prevention, or treatment of ovarian cancer. The award encourages proposals from both established ovarian cancer researchers and investigators from other cancer disciplines, fostering multidisciplinary collaboration. Projects should be high-risk, high-reward, and may span basic, translational, or clinical research. The program’s goal is to accelerate breakthroughs by enabling bold ideas that may not be funded through traditional mechanisms.
